MEDFIELD DIAGNOSTICS AB MEDDELAR ATT MAN LÅST DEN FÖRSTA ALGORITMEN FÖR STROKE Utvecklingsarbetet och den kliniska insamlingen av data har nu resulterat i att den första algoritmen i MD100 har… läs mer
Medfield Diagnostics AB receives SEK 5,2 million through the redemption of warrants and directed new share issue (SWE)
Den 16 december 2020 avslutades nyttjandeperioden för Medfield Diagnostics ABs (publ) (”Medfield” eller ”Bolaget”) teckningsoptioner av serie TO 1. Totalt nyttjades 1 497 547 teckningsoptioner av serie TO 1, vilket innebär en… läs mer
11 September, 2019
On September 10, Medfield Diagnostics AB hosted a Health Minister’s visit from Australia NSW. The Minister and his delegation were particularly interested in discussing Medfield’s opportunities to collaborate in the development of pre-hospital stroke and trauma care and the use of the Medfield MD100 system.
The background to the visit is Medfield’s ongoing collaboration with the Hunter Medical Research Institute, which includes clinical verification of Medfield’s MD100 system.
5 July, 2019
Great interest when Medfield participates in the ESOC and Vitalis conferences.ESOC stand for the European Stroke Organisation Conference. An annual conference where Europe’s leading researchers in stroke are networking and present their projects.VitalisTogether with the University of Borås, the Ambulance at Sahlgrenska University Hospital, the Västra Götaland region, the Ambulance operations at SKAS and SÄS, Medfield Diagnostics AB and GM Medical AB run PICTA – Prehospital ICT Arena, at Lindholmen Science Park, the PreTest project, which started after receiving funding from Vinnova. During Vitalis, the mobile test bed (PreTest) was shown and how MD100 can be integrated in the prehospital care process.